In vivo and ex vivo responses of CLL cells to purine analogs combined with alkylating agent-Reference-Cited by-同舟云学术

In vivo and ex vivo responses of CLL cells to purine analogs combined with alkylating agent

Published:2013-03 Issue:2 Volume:65 Page:460-475
ISSN:1734-1140
Container-title:Pharmacological Reports
language:en
Short-container-title:Pharmacological Reports

Author:

Żołnierczyk Jolanta D.,Borowiak Arleta,Błoński Jerzy Z.,Cebula-Obrzut Barbara,Rogalińska Małgorzata,Kotkowska Aleksandra,Wawrzyniak Ewa,Smolewski Piotr,Robak Tadeusz,Kiliańska Zofia M.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,General Medicine

Reference52 articles.

1. A novel CDK inhibitor, CYC202 (R-roscovitine), overcomes the defect in p53-dependent apoptosis in B-CLL by downregulation of genes involved in trans-cription regulation and survival;Alvi;Blood,2005

2. In vitro evaluation of fludarabine in combination with cyclophosphamide and/or mitoxantrone in B-cell chronic lymphocytic leukemia;Bellosillo;Blood,1999

3. Apoptosis at the inter-face of immunosuppressive and anticancer activities: the example of two classes of chemical inducers, oxysterols and alkylating agents;Bischoff;Curr Med Chem,2000

4. Nuclei from rat liver: isolation method that combines purity with high yield;Blobel;Science,1966

5. The role of Bcl-2 family proteins in chronic lymphocytic leukemia;Buggins;Leuk Res,2010

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vitro antileukemic activity of novel adenosine derivatives bearing boron cluster modification;Bioorganic & Medicinal Chemistry;2016-11

2. Towards the Application of Atorvastatin to Intensify Proapoptotic Potential of Conventional Antileukemic AgentsIn Vitro;Journal of Chemistry;2015